메뉴 건너뛰기




Volumn 57, Issue 2, 1996, Pages 123-130

Tolerability of oral pamidronate in elderly patients with osteoporosis and other metabolic bone diseases

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

EID: 0029862962     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80006-3     Document Type: Article
Times cited : (17)

References (14)
  • 1
    • 0023520871 scopus 로고
    • Paget's disease of bone: Early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD)
    • Harinck HIJ, Papapoulos SE, Blanksma HJ, et al. Paget's disease of bone: Early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). BMJ. 1987;295:1301-1305.
    • (1987) BMJ , vol.295 , pp. 1301-1305
    • Harinck, H.I.J.1    Papapoulos, S.E.2    Blanksma, H.J.3
  • 2
    • 0020327529 scopus 로고
    • Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium
    • van Breukelen FJM, Bijvoet OLM, Frijlink WB, et al. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium. Calcif Tissue Int. 1982;34:321-327.
    • (1982) Calcif Tissue Int , vol.34 , pp. 321-327
    • Van Breukelen, F.J.M.1    Bijvoet, O.L.M.2    Frijlink, W.B.3
  • 3
    • 0023200599 scopus 로고
    • Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment
    • van Holten-Verzantvoort AT, Bijvoet OLM, Cleton FJ, et al. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet. 1987;2:983-985.
    • (1987) Lancet , vol.2 , pp. 983-985
    • Van Holten-Verzantvoort, A.T.1    Bijvoet, O.L.M.2    Cleton, F.J.3
  • 4
    • 0026167084 scopus 로고
    • Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis
    • Fromm GA, Vega E, Plantalech L, et al. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporosis Int. 1991;1:129-133.
    • (1991) Osteoporosis Int , vol.1 , pp. 129-133
    • Fromm, G.A.1    Vega, E.2    Plantalech, L.3
  • 5
    • 0028923309 scopus 로고
    • Long-term tolerability of nasal spray formulation of salmon calcitonin
    • Foti R, Martorana U, Broggini M. Long-term tolerability of nasal spray formulation of salmon calcitonin. Curr Ther Res. 1995;56:429-435.
    • (1995) Curr Ther Res , vol.56 , pp. 429-435
    • Foti, R.1    Martorana, U.2    Broggini, M.3
  • 6
    • 0021266190 scopus 로고
    • Side effects of disodium aminohydroxypropylidene diphosphonate (APD) during treatment of bone diseases
    • Mautalen CA, Casco CA, Gonzalez D, et al. Side effects of disodium aminohydroxypropylidene diphosphonate (APD) during treatment of bone diseases. BMJ. 1984;288:828-829.
    • (1984) BMJ , vol.288 , pp. 828-829
    • Mautalen, C.A.1    Casco, C.A.2    Gonzalez, D.3
  • 7
    • 0038289612 scopus 로고
    • Treatment of Paget's disease with the bisphosphonate APD. A biological and radiological study
    • Donath A, Curvoisier B, eds. Geneva: Medicine et Hygiene
    • Nagant de Deuxchaisnes C, Rombouts-Lindesmans C, Huaux JP, et al. Treatment of Paget's disease with the bisphosphonate APD. A biological and radiological study. In: Donath A, Curvoisier B, eds. Diphosphonates and Bone. Geneva: Medicine et Hygiene; 1982:303-327.
    • (1982) Diphosphonates and Bone , pp. 303-327
    • Nagant De Deuxchaisnes, C.1    Rombouts-Lindesmans, C.2    Huaux, J.P.3
  • 8
    • 0025814846 scopus 로고
    • Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases
    • Coleman RE, Dirix LY, Dodwell D, et al. Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases. Eur J Cancer. 1991;27:945-946.
    • (1991) Eur J Cancer , vol.27 , pp. 945-946
    • Coleman, R.E.1    Dirix, L.Y.2    Dodwell, D.3
  • 10
    • 1842852118 scopus 로고
    • Side effects verified during the treatment of 228 cases of involutional osteoporosis with pamidronate
    • Abstract
    • Fromm GA, Vega E, Galich AM, et al. Side effects verified during the treatment of 228 cases of involutional osteoporosis with pamidronate. Bone Miner. 1992;17(Suppl):S17. Abstract.
    • (1992) Bone Miner , vol.17 , Issue.SUPPL.
    • Fromm, G.A.1    Vega, E.2    Galich, A.M.3
  • 11
    • 0028606037 scopus 로고
    • Pamidronate: An unrecognized problem in gastrointestinal tolerability
    • Lufkin EG, Argueta R, Whitaker MD, et al. Pamidronate: An unrecognized problem in gastrointestinal tolerability. Osteoporosis Int. 1994;4:320-322.
    • (1994) Osteoporosis Int , vol.4 , pp. 320-322
    • Lufkin, E.G.1    Argueta, R.2    Whitaker, M.D.3
  • 12
    • 0029130033 scopus 로고
    • Oral bisphosphonates in the treatment of osteoporosis: A review
    • Francis RM. Oral bisphosphonates in the treatment of osteoporosis: A review. Curr Ther Res. 1995;56:831-851.
    • (1995) Curr Ther Res , vol.56 , pp. 831-851
    • Francis, R.M.1
  • 13
    • 0028200995 scopus 로고
    • Effects of two oral doses of alendronate in the treatment of Paget's disease of bone
    • Adami A, Mian M, Gatti P, et al. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. Bone. 1994;15:415-417.
    • (1994) Bone , vol.15 , pp. 415-417
    • Adami, A.1    Mian, M.2    Gatti, P.3
  • 14
    • 0023632357 scopus 로고
    • The acute phase response after bisphosphonate administration
    • Adami S, Bhalla AK, Dorizzi R, et al. The acute phase response after bisphosphonate administration. Calcif Tissue Int. 1987;41:326-331.
    • (1987) Calcif Tissue Int , vol.41 , pp. 326-331
    • Adami, S.1    Bhalla, A.K.2    Dorizzi, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.